Literature DB >> 33186634

Role, function and regulation of the thymocyte selection-associated high mobility group box protein in CD8+ T cell exhaustion.

Yanmin Cheng1, Zhaozhao Shao2, Li Chen3, Qiaoyu Zheng4, Qiqi Zhang5, Wenjie Ding6, Meng Zhang7, Qiongfang Yu8, Dian Gao9.   

Abstract

Thymocyte selection-associated high mobility group box protein (TOX), a member of the high-motility group box (HMG) protein superfamily, is an evolutionarily conserved DNA-binding protein. It functions as a transcription factor that modulates transcriptional programs by binding to DNA in a structure-dependent manner. It has been well established that TOX is required for the development of CD4+ T cells, natural killer (NK) cells and innate lymphoid cells (ILCs), as well as the autoimmunity mediated by CD8+ T cells. Recently, emerging evidence supports an essential role for TOX in the induction of T cell exhaustion in the setting of tumor or chronic viral infection by mediating transcriptional and epigenetic changes, which are cardinal hallmarks of exhausted T cells. Moreover, TOX plays a key role in the persistence of antigen-specific T cells and in the mitigation of tissue damage caused by immunopathology over the course of tumorigenesis and chronic infection. Additionally, TOX contributes to the high level of programmed cell death protein 1 (PD-1) on the cell surface by participating in the process of endocytic recycling of PD-1. In this review, we summarize the most recent information about the role of TOX in the process of T cell exhaustion, which enriches our understanding of the molecular mechanisms of CD8+ T cell exhaustion upon chronic antigen stimulation and reveals promising therapeutic targets for persisting infection and cancer.
Copyright © 2020 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Checkpoint blockade; PD-1; T cell exhaustion; TOX; Thymocyte selection-associated high mobility group box protein

Mesh:

Substances:

Year:  2020        PMID: 33186634     DOI: 10.1016/j.imlet.2020.11.004

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  2 in total

Review 1.  TOX as a potential target for immunotherapy in lymphocytic malignancies.

Authors:  Chaofeng Liang; Shuxin Huang; Yujie Zhao; Shaohua Chen; Yangqiu Li
Journal:  Biomark Res       Date:  2021-03-20

2.  Identification of Differentially Expressed Genes and Prediction of Expression Regulation Networks in Dysfunctional Endothelium.

Authors:  Fang Cheng; Yujie Zeng; Minzhu Zhao; Ying Zhu; Jianbo Li; Renkuan Tang
Journal:  Genes (Basel)       Date:  2022-08-30       Impact factor: 4.141

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.